GeneralConnection.com ➔ Dictionary
Dictionary Search

hematologic

Synonyms

Adjective

1. haematological

2. hematological, medicine, medical specialty

Usage
NCCN 2026 Annual Congress: Hematologic Malignancies - Oncodaily
Hematologists Highlight Top Data From ASCO 2026 - OncLive
Incyte to Acquire Vega Therapeutics for Up-to-$2B, Growing Hematology Pipeline with Phase III VWD Candidate - Genetic Engineering and Biotechnology News
Blastic Neoplasm Therapy Decnupaz Approved - Clinical Oncology News
Nurse-Led Quality Initiative Reduces CLABSI Risk in Hematologic Cancer Care - Cure Today
EHA 2026: Hematology Comes to Stockholm With Patients at the Forefront - AJMC
Aplastic Crisis Triggered by Parvovirus B19 in an Adult Man With Sickle Cell Disease - Cureus
DISC-0974 Produces Meaningful Hematologic Responses in Myelofibrosis-Associated Anemia - Targeted Oncology
Incyte to Buy Vega Therapeutics in Hematology Deal Worth Up to $2B - Zacks Investment Research
RALLY-MF: Anti-Hemojuvelin Antibody DISC-0974 Yields Hematologic Responses in Patients With Anemia and Myelofibrosis - ASCO Daily News
FDA Approves Pivekimab Sunirine in Rare Hematologic Malignancy - CancerNetwork
Florida Oncology and Hematology and American Oncology Network Welcome Dr. Vitor Pastorini - markets.businessinsider.com
Understanding the Psychoneurological Symptom Cluster in Adults With Hematologic Malignancies - Oncology Nursing News
Oral Therapy Enables At-Home Treatment for Acute Myeloid Leukemia | Newswise - Newswise
Incyte snaps up Vega Therapeutics in $2bn hematology play - BioXconomy
Dr Patel on Data for Orca-T With RIC in Hematologic Malignancies - OncLive
Amer Zeidan: Farewell Party to Our Medical Oncology and Hematology Chief Roy Herbst - Oncodaily
Teclistamab EarlyLine Survival Gains in Multiple Myeloma - Clinical Oncology News
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy - Oncodaily
Amer Zeidan: Yale Hematology Celebrates Career Transitions and New Faculty Appointments - Oncodaily
Frontline Combos Take the Spotlight: Previewing the Top Hematologic Oncology Presentations at ASCO 2026 - OncLive
Shifting Hematologic and Solid Tumor Units to Progressive Care Models - CancerNetwork
Cancer doctor Vitor Pastorini now seeing patients in Fort Myers, Cape Coral - Stock Titan
Interpretable multiple instance learning for hematologic diagnosis from peripheral blood smears - Nature
Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies - Nature
Investigating blood cell images for enhanced hematologic disorder detection using multi-scale feature learning with a hybrid deep learning model - Nature
Selinexor and Ruxolitinib Combo Shows Promise for Myelofibrosis - Oncology News Central
Register Today for Roswell Park’s Upstate New York Hematology & Hematologic Oncology Conference - Roswell Park Comprehensive Cancer Center
Incyte to Acquire Vega Therapeutics in Up to $2 Billion Hematology Expansion - citybiz
Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee - Nature
Society of Hematologic Oncology opens registration for case-based MDS/AML program ahead of SOHO 2026 - PR Newswire
Timing Is Everything: Advancing Genomic Testing in Hematologic Malignancies - HCPLive
Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies - ASCO Publications
Unveiling economic and humanistic burden of hematologic malignancies in Japan with personal health record data - Nature
Ocular toxicities of targeted therapies and immunotherapies in hematologic malignancies - Frontiers
Next‑Generation CAR‑T and Bispecific Immune‑Effector Therapies in Hematologic Malignancies - Nature
Solving Riddles Through Sequencing (SIRIUS): unlocking hematologic diagnoses by whole genome and transcriptome sequencing | Leukemia - Nature
5 Ongoing Phase 3 Trials in Hematologic Malignancies - AJMC
Orca-T May Make Transplants Safer, More Effective in Hematologic Cancers - CancerNetwork
FDA Approves Ruxolitinib Tablets for Hematologic Malignancies - CancerNetwork
Optimizing Symptom Management in Hematologic Oncology: Empowering Oncology Nurses - Cancer Nursing Today
Dr. Vitor Pastorini Joins Florida Oncology and Hematology and American Oncology Network - geneonline.com
Pathophysiology, evaluation, and management of malnutrition in hematologic malignancies: a comprehensive review - Frontiers
Hematologic and coagulation responses to Johnson & Johnson COVID-19 vaccination in the Amhara region, Ethiopia - Nature
Orca-T May Be “Important Step Forward” in Hematologic Malignancy Care - CancerNetwork
Dr Smith on Translating CAR T-Cell Therapies From Hematologic to Solid Malignancies - OncLive
Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk - NEJM
ChatGPT Found Lacking for Hematologic Cancers - Hematology Advisor
Managing Hematologic Toxicities with ADCs: Neutropenia, Growth Factor Support, and Thrombocytopenia in Breast and Lung Cancer - OncLive
Incyte makes $2B bleeding disorder play - Axios
Shifting Towards Cell Therapy Optimization Across Hematologic Malignancies - CancerNetwork
Orca-T and Orca-Q Set the Stage for the Future for GVHD Management in Hematologic Malignancies - OncLive
Insights Across Hematologic Oncology at Columbia University - CancerNetwork
Reducing the Barriers to Receiving CAR T-Cell Therapy for Patients With Hematologic Malignancies - The ASCO Post
The Evolving Treatment Landscape: Nurse Practitioners Reflect on Progress in Hematologic Oncology at ASH 2025 - Cancer Nursing Today
Orca-T Shows “Reassuring” Outcomes Across Hematologic Malignancies - CancerNetwork
Hematologic Malignancies Market Size is Projected to Reach - GlobeNewswire
INDEPENDENCE, Type II JAK Inhibitor Data Highlight Key MPN and AML Data Arriving at EHA 2026 - OncLive
FDA Grants RMAT Designation to Orca-Q for High-Risk Hematologic Malignancies - OncLive
Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies - Nature
AbbVie showcases broad blood cancer pipeline at EHA 2026 with 21 presentations - Indian Pharma Post
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact - Nature
Cathy Eng: Celebrating the Vanderbilt Hematology and Oncology Fellowship Class of 2026 - Oncodaily
Orca-T Diversifies Well-Tolerated Post-Transplant Treatment Options for Hematologic Malignancies - OncLive
Talha Badar: Key Hematologic Malignancy Posters from ASCO26 - Oncodaily
ASH 2025: The Top 10 Takeaways for Hematologic Oncology Care - CancerNetwork
Incyte to Acquire Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio into Bleeding Disorders - BioSpace
Incyte To Acquire Vega Therapeutics For Up To $2 Billion To Expand Hematology Portfolio Into Bleeding Disorders - Pulse 2.0
FDA Extends Review Period for Orca-T in Hematologic Malignancies - CancerNetwork
T cells engineered against Dickkopf-1-A2 complex can be used to treat HLA-A2+ solid and hematologic cancers - Nature
Celebrating 30 Years with DOIM: A Conversation on Hematology, Leadership, and APC Growth - School of Medicine | University of Utah
The Role of Artificial Intelligence in Palliative Oncology: Zeroing in on Hematologic Malignancies - CancerNetwork
Top Early Phase Hematologic Oncology Trials to Watch at EHA 2026 - Oncodaily
Could Hematologic Markers Be Prognostic for Survival in RCC? - CancerNetwork
Hematology Launches Virtual Iron Deficiency Clinic - School of Medicine | University of Utah
To Drive Value in Hematology Research, We Must Prioritize the Patient Experience - AJMC
FDA Extends Review of BLA for Orca-T in Hematologic Malignancies - OncLive
Incorporating mRNA therapeutics into biological treatments of hematologic malignancies - Frontiers
Sepsis detection in hematologic and solid tumor malignancies using quantitative inflammatory biomarker differences in a prospective single center study - Nature
Metabolic reprogramming in tumor-associated cells of hematologic malignancies: mechanisms, crosstalk networks, and therapeutic implications in the tumor microenvironment - Frontiers
Hematologic Oncologists Share Conference Must-Haves - OncLive
Liquid Biopsy in Hematologic Malignancies: Advances, Challenges, and Future Directions - Wiley Online Library
Binaytara's 2026 National Summit on Hematologic Cancers Reinvents the Medical Conference -- and Invests $250,000 Behind the Next Generation of Researchers - PR Newswire
APP-Led Benign Hematology Consults Reduce Wait Times and Expand Access in Community Oncology - Pharmacy Times
FDA Grants Priority Review to Orca-T for Hematologic Malignancies - OncLive
ANCO’s Hematologic Malignancies Update 2026 - Oncodaily
AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026 - Investing News Network
SOHO 2025 Keynote Speakers Highlight Progress in Hematologic Oncology - The ASCO Post
Iron Overload Linked to Worse HSCT Outcomes Among Pediatric Patients With Nonmalignant Hematologic Disorders - Docwire News
CAR-T in hematologic malignancy: inpatient delivery drives major utilization without higher in-hospital mortality - Vera Health
Analysis Shows Consistent Manufacturing and Distribution of Orca-T in Hematologic Malignancies - OncLive
Orca-T With Reduced-Intensity Conditioning Yields Robust Efficacy in Hematologic Malignancies - OncLive
Orca-T With Reduced Intensity Conditioning Is Safe and Feasible in Hematologic Malignancies - OncLive
Incyte To Acquire Vega Therapeutics, A Wholly Owned Subsidiary Of Star Therapeutics, Expanding Its Hematology Portfolio Into Bleeding Disorders - TradingView
New Data Highlight Pharmacists’ Expanding Roles in Hematologic Malignancies - Pharmacy Times
Incyte’s stars align as new CEO strikes $2B Vega takeover for blood disorder asset - BioSpace
TGF-β in hematologic malignancies: molecular functions and clinical applications - Frontiers
Myeloablative Orca-Q Yields High Engraftment Rates in High-Risk Hematologic Malignancies With Haploidentical Donors - OncLive
Concentration–QTc Analysis of Valemetostat in Patients With Hematologic Malignancies - Wiley
Utah Center for Bleeding & Clotting Disorders at University of Utah Health Administers New Gene Therapy for Hemophilia B - School of Medicine | University of Utah
Foreign Language Equivalents
Foreign Language Equivalents of 'hematologic'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
hematlogic,   hematolohic,   hematoolgic,   hhematologic,   hematloogic,   henatologic,   hemaologic,   heamtologic,   hemtaologic,   hematologicc,   hematoloic,   jematologic,   hemarologic,   hematologgic,   hmeatologic,   hematolofic,   ematologic,   hematoloogic,   hmatologic,   hematologci,   hematologiic,   hematokogic,   hematoogic,   gematologic,   hematplogic,   hemattologic,   hemmatologic,   hematologiv,   hemaotlogic,   hematologi,   he,atologic,   hematollogic,   ehmatologic,   hematologoc,   hematilogic,   hematoligic,   hemaatologic,   hrmatologic,   hematologc,   hemayologic,   hemato;ogic,   hemtologic,   hemstologic,   hematoologic,   hematologuc,   hematolgic,   hematolgoic,   heematologic,   hematoloigc,   hematologix,   heatologic,   hwmatologic,   hematolpgic
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z